Lawsuit News Lawsuit News Releases

Medical Device News

Pharmaceutical Lawsuit News

Lawsuit FAQs
Legal Glossary

Multi-District Litigation News

Bookmark and Share

Testosterone Heart Attack & Stroke Lawsuit News

Testosterone replacement drugs, those marketed for "Low T", have been shown to pose a two to three times higher risk of heart attack and stroke than normal.   These drugs include:

  • Androderm
  • Androgel
  • Android 10
  • Android 25
  • Axiron
  • Delatestryl
  • Depo-Testosterone
  • Fortesta
  • Striant
  • Testim
  • Testopel
  • Testosterone
  • Testosterone Cypionate
  • Testosterone Enanthate
  • Testred
  • Vogelxo

More than 3 million prescriptions for testosterone replacement drugs were written in 2012, with total sales from these drugs exceeding $2 billion.   The marketing of these drugs have received significant scrutiny in recent years for encouraging use without acknowledging the risks.

Testosterone attorneys are now investigating cases where a user of a testosterone therapy drug was taken and subsequently suffered a heart attack or stroke.

Testosterone Lawsuit News Releases

Continue to check back frequently for news, press releases and updates for the Testosterone Replacement Products Liability Litigation

Testosterone Heart Attack and Stroke Lawsuit Legal Help

If you or a family member suffered a heart attack or stroke after taking a testosterone replacement drug, please visit our website at to learn more information about Testosterone replacement heart attack and stroke lawsuits and to contact testosterone heart attack lawyers.

Other Testosterone Lawsuit Information